150mg group was doing numerically better than 300mg group (in efficacy terms)It's interesting indeed and they didn't say if this group also did better in safety but they only took the 150mg dose to phase III anyway. How many MS drugs BIIB can put on the market? Drugs with different profile and the same marketing force, so the more the merrier :)